0001213900-18-008697.txt : 20180703
0001213900-18-008697.hdr.sgml : 20180703
20180703160729
ACCESSION NUMBER: 0001213900-18-008697
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180628
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu Lei
CENTRAL INDEX KEY: 0001472651
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34711
FILM NUMBER: 18937156
MAIL ADDRESS:
STREET 1: ROOM 507-513, 5TH FLOOR,A BUILDING
STREET 2: MEIDU PLAZA, GONGSHU DISTRICT
CITY: HANGZHOU
STATE: F4
ZIP: 310011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHINA JO-JO DRUGSTORES, INC.
CENTRAL INDEX KEY: 0001413263
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 980557582
FISCAL YEAR END: 0730
BUSINESS ADDRESS:
STREET 1: HAI WAI HAI TONGXIN MANSION FLOOR 6
STREET 2: GONG SHU DISTRICT, HANGZHOU
CITY: ZHEJIANG PROVINCE
STATE: F4
ZIP: 310008
BUSINESS PHONE: (86) 1501-158-6601
MAIL ADDRESS:
STREET 1: HAI WAI HAI TONGXIN MANSION FLOOR 6
STREET 2: GONG SHU DISTRICT, HANGZHOU
CITY: ZHEJIANG PROVINCE
STATE: F4
ZIP: 310008
FORMER COMPANY:
FORMER CONFORMED NAME: KERRISDALE MINING CORP
DATE OF NAME CHANGE: 20070924
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2018-06-28
0
0001413263
CHINA JO-JO DRUGSTORES, INC.
CJJD
0001472651
Liu Lei
HAI WAI HAI TONGXIN MANSION FLOOR 6,
GONG SHU DISTRICT
HANGZHOU CITY
F4
310008
CHINA
1
1
1
0
CEO, Chairman of the Board
Common Stock
2018-06-28
4
J
0
225000
0
D
8825482
D
Represents 225,000 shares of common stock cancelled by the compensation committee so that it fits within the 675,000 share limitation in Section 1.3.2 of the China Jo-Jo Drugstores, Inc. 2010 Equity Incentive Plan (the "Plan").
The number of securities reported under Item 5 of Table I includes, but not limited to 6,030,000 shares held by Super Marvel Limited, of which the Reporting Person is the executive director and a shareholder, and as such, is deemed to have or share voting and investment controls over such shares.
The Tax Cuts and Jobs Act of 2017 removed the 162(m) qualified performance based compensation exemption to the $1 million cap on deductions for compensation to covered executives. Section 1.3.2 was in the Plan to permit grants under the Plan to fit within that exemption. As that exemption no longer applies for grants made in 2018 or thereafter, the Plan has been amended to remove the provisions intended to comply with that exemption, including the one in Section 1.3.2. of the Plan.
/s/ Lei Liu
2018-07-03